Structure Therapeutics Inc ADR [NASDAQ: GPCR] jumped around 18.54 points on Monday, while shares priced at $52.74 at the close of the session, up 54.21%.
Compared to the average trading volume of 606.81K shares, GPCR reached a trading volume of 11684969 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Structure Therapeutics Inc ADR [GPCR]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GPCR shares is $79.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GPCR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Structure Therapeutics Inc ADR shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 21, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 09, 2024, representing the official price target for Structure Therapeutics Inc ADR stock. Previously, the target price had yet another raise to $90, while JMP Securities analysts kept a Mkt Outperform rating on GPCR stock.
The Average True Range (ATR) for Structure Therapeutics Inc ADR is set at 4.20 The Price to Book ratio for the last quarter was 5.72, with the Price to Cash per share for the same quarter was set at 9.36.
How has GPCR stock performed recently?
Structure Therapeutics Inc ADR [GPCR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 42.31. With this latest performance, GPCR shares gained by 35.27% in over the last four-week period, additionally sinking by -5.30% over the last 6 months – not to mention a rise of 64.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GPCR stock in for the last two-week period is set at 77.39, with the RSI for the last a single of trading hit 82.62, and the three-weeks RSI is set at 72.17 for Structure Therapeutics Inc ADR [GPCR]. The present Moving Average for the last 50 days of trading for this stock 38.77, while it was recorded at 38.80 for the last single week of trading, and 44.43 for the last 200 days.
Structure Therapeutics Inc ADR [GPCR]: Deeper insight into the fundamentals
Structure Therapeutics Inc ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 19.05 and a Current Ratio set at 19.05.
Insider trade positions for Structure Therapeutics Inc ADR [GPCR]
The top three institutional holders of GPCR stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in GPCR stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in GPCR stock with ownership which is approximately 5.8386%.
